Skip to content

Russell Lipford

Russell Lipford

Company: Amgen

Job title: Director, Oncology Research


Pre-Clinical Development of AMG 510: The First Inhibitor of KRASG12C in Clinical Testing 8:30 am

AMG 510 is a covalent inhibitor of KRASG12C that exploits a unique groove to enhance potency and selectivity AMG 510 treatment gives rise to robust pre-clinical efficacy in multiple settings as monotherapy and in combination with SOC and targeted therapies AMG 510 inflames tumor cells and drives anti-tumor immunity in a syngeneic tumor model in…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.